Advancing the Science

Mayo Clinic Medical Science Blog – an eclectic collection of research- and research education-related stories: feature stories, mini news bites, learning opportunities, profiles and more from Mayo Clinic.

August 30, 2013

Vedolizumab Effective for Treatment of Ulcerative Colitis/Crohn’s Disease – IBD in the News


Sunanda Kane, M.D., a gastroenterologist at Mayo Clinic specializing in the care and evaluation of patients with IBD, discusses two studies recently published in “The New England Journal of Medicine” (ulcerative colitis study | Crohn's disease study) that found patients with ulcerative colitis or Crohn’s disease benefited from treatment with vedolizumab compared with placebo.

Dr. Kane also discusses how the mechanism of action for vedolizumab differs from other therapies currently used to treat IBD.

For more information on IBD, visit:

Tags: Crohn's disease, Findings, gastroenterology, IBD, inflammatory bowel disease, ulcerative colitis

Please login or register to post a reply.
Contact Us · Privacy Policy